Profile: SemBioSys Genetics Inc. is a biotechnology company developing insulin and other protein-based pharmaceuticals. Our products are used in metabolic and cardiovascular diseases. We also offer a series of non-pharmaceutical products. Our Apo AI is a cardiovascular therapy which reduces and stabilizes plaque associated with acute coronary syndrome & stroke. Our StratoCapture™ is a reagent that offers the potential to transform the capital intensive, expensive batch purification process for monoclonal antibody products.